Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Total 13F shares
-
1,269,848,724
-
Share change
-
-18,632,940
-
Total reported value
-
$293,756,859,622
-
Put/Call ratio
-
84%
-
Price per share
-
$231.54
-
Number of holders
-
3,873
-
Value change
-
-$3,127,115,616
-
Number of buys
-
1,891
-
Number of sells
-
1,568
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q3 2025
As of 30 Sep 2025,
AbbVie Inc. - Common Stock (ABBV) was held by
3,873 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,269,848,724 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, JPMORGAN CHASE & CO, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Capital Research Global Investors, BANK OF AMERICA CORP /DE/, and NORTHERN TRUST CORP.
This page lists
3,873
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.